Kentucky is seriously considering researching ibogaine as a mental health treatment, for potential rapid-acting and long-lasting benefits. Why Kentucky? And why know? By registering for this webinar, you will have the unique opportunity to hear first-hand from Juliana Mulligan, founder of Inner Vision Ibogaine, about how this came to be and the potential benefits of […]

The post Ibogaine Revealed: Unpacking Kentucky’s Vote on Transformative Drug Treatment Opportunity appeared first on Psychedelics Today.

Previous articleReal Harm Reduction Requires Redistribution of Wealth
Next articlePsychedelic Bulletin #X